nei THIS MONTH IN
PSYCHOPHARMACOLOGY
Browsing articles in "Pregnancy/Postpartum"

 

Risk of Congenital Malformations With Stimulant Use During Pregnancy
February 16, 2018   

In a recent cohort study from the International Pregnancy Safety Consortium the relationship between intrauterine exposure to stimulants, such as methylphenidate and amphetamine and risk of...
 Continue reading
Review: Benefits vs. Risks of Aripiprazole During Pregnancy
February 7, 2018   

A systematic literature search and review evaluated the available data on the use of aripiprazole during pregnancy, peripartum and lactation...
 Continue reading (Members only)
Do Anxiety Disorders During Pregnancy Increase Risk of Adverse Birth Outcomes?
October 13, 2017   

The decision to treat mental health conditions, such as anxiety disorders, during pregnancy is an important and personal one; the health of the mother must be carefully weighed against potential adverse outcomes to the fetus. A recently published study adds valuable data on which such decisions can be informed....
 Continue reading (Members only)
Perinatal Antidepressant Use and Psychiatric Disorders in Offspring
September 29, 2017   

A recent Danish cohort study examined the association between in utero exposure to antidepressants and risk of psychiatric disorders...
 Continue reading (Members only)
Maternal and Postpartum Depression: Risk Factors, Mortality, and Child Outcomes
May 31, 2017   

Depression during the postpartum period is not uncommon, with prevalence rates as high as 20% (and perhaps even more prevalent in low-income countries). Recent years have called for increased recognition of postpartum depression, reduction of associated stigma, and support for new mothers in need of treatment...
 Continue reading
Antidepressants and Risk for Autism, ADHD
May 12, 2017   

Recently published studies suggests that mothers' use of antidepressants during early pregnancy does not increase the risk of their children developing autism or attention deficit hyperactivity disorder, conditions previously associated with these medications....
 Continue reading (Members only)
Marijuana Use in Pregnant Women Has Increased
January 13, 2017   

In a recent observational study, the prevalence of marijuana use in pregnant versus nonpregnant women was examined...
 Continue reading (Members only)
Prenatal and Postpartum Depression Linked to Altered Brain Structure in Offspring
December 10, 2016   

Prenatal depression is associated with alterations in gray matter in infants and young children; however, the relationship between postpartum depression and white matter development in children’s brains is unclear...
 Continue reading (Members only)
Congenital Malformations Not Seen With Antipsychotic Use During Pregnancy
September 6, 2016   

Results from a large retrospective study found that antipsychotic use during pregnancy does not significantly increase the risk of birth defects. Krista F. Huybrechts, MS, PhD and colleagues examined the association between antipsychotic (AP) use during the first trimester and the risk of congenital malformations...
 Continue reading (Members only)
Depression in Pregnancy: Studies on Universal Screening and on Effects of Untreated Depression
June 24, 2016   

A new study published by Venkatesh and colleagues showed universal screening for depression during pregnancy is both feasible and can lead to increased detection, subsequent intervention, and improved depressive symptom outcomes. Researched examined 8,985 women who were enrolled in prenatal care between July 2010 and June 2014. A total of 8,840 women...
 Continue reading (Members only)
12
Top of Page